TABLE 2.
Region | Fold-change in PDD (this study) | Fold-changes in AD (Xu et al., 2016) | Fold-changes in HD (Patassini et al., 2015) |
CB | 3.7 | 4.9 | 3.6 |
MCX | 4.1 | 5.0 | 3.4 |
PVC | 4.3 | 4.9 | 3.4 |
HP | 4.2 | 6.5 | 3.6 |
SN | 3.9 | – | 3.5 |
MTG | 4.3 | 4.7 | 3.4 |
MED | 4.6 | – | – |
CG | 5.5 | 5.3 | 3.5 |
PONS | 3.9 | – | – |
PUT | – | – | 3.7 |
GP | – | – | 3.6 |
MFG | – | – | 3.0 |
ENT | – | 5.6 | 2.8 |
Overall | 4.3 (3.9–4.6) | 5.3 (4.8–5.8) | 3.5 (3.2–3.6) |
Comparisons of case-control fold-changes in human brain urea levels between PDD, AD, and HD. Case-control differences were significant for every region in every disease. Overall shows mean overall fold-change with ± 95% confidence intervals.